Contact Now
Send Message
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shaanxi Kaishi Biotechnology Co., Ltd
$28
1-199 Others
$22
200-499 Others
$18
≥500 Others
Product Description
Bovine Bone Marrow Peptide Capsules are nutritional products containing enzymatically hydrolyzed peptide fractions derived from bovine bone marrow materials. Designed for peptide nutrition, protein-based wellness, healthy-aging, and specialized nutraceutical formulations, they offer a convenient dosage form where molecular-weight distribution, protein content, solubility, raw-material traceability, and microbiological control are key B2B purchasing factors.
Bovine bone marrow peptide is not a single purified molecule. It is a complex mixture of peptides and amino-acid-containing fractions generated through controlled protein hydrolysis, followed by separation, concentration, purification, and drying. The resulting peptide powder can be formulated into hard capsules as a standalone ingredient or combined with complementary Nutritional Ingredients.
Because peptide ingredients vary substantially with raw material and hydrolysis conditions, commercial quality should not be judged from a generic “bone marrow peptide” description alone. Buyers should evaluate protein and peptide content, molecular-weight distribution, hydrolysis consistency, sensory properties, contaminant controls, and the suitability of the powder for capsule filling.
| Item | Specification |
|---|---|
| Product Name | Bovine Bone Marrow Peptide Capsules |
| Ingredient Type | Hydrolyzed animal-derived peptide ingredient |
| Raw Material Source | Bovine bone marrow-derived protein material |
| Product Category | Animal Peptide / Nutritional Ingredient Capsules |
| CAS Number | Not applicable as a universal single CAS number because the ingredient is a complex peptide mixture |
| Molecular Formula | No single molecular formula; composition consists of multiple peptides and amino-acid-containing fractions |
| Molecular Weight | No single molecular weight; commercial specifications are defined by peptide molecular-weight distribution |
| Typical Appearance | Off-white to light yellow or light beige fine powder |
| Production Method | Controlled enzymatic hydrolysis followed by separation, purification, concentration, and drying |
| Common Grade | Food or nutraceutical-grade peptide powder with defined protein, peptide, and molecular-weight specifications |
| Protein and Peptide Content | Standardized according to the intended formulation; higher peptide-content and low-molecular-weight fractions can be selected according to application requirements |
| Molecular-Weight Profile | Controlled peptide distribution with low-molecular-weight fractions selectable according to formulation requirements |
| Standard Test Methods | Kjeldahl or Dumas method for protein; validated peptide-content analysis and size-exclusion or gel-permeation chromatography for molecular-weight distribution |
| Solubility | Generally dispersible to soluble in water depending on peptide size, concentration, and processing method |
| Flavor and Odor | Characteristic peptide profile with sensory characteristics controlled through purification and processing |
| Capsule Shell | Hard gelatin or vegetarian HPMC capsule options |
| Capsule Fill | Customized according to peptide concentration, powder density, capsule size, serving configuration, and formulation requirements |
| Particle Size | Controlled or customized for powder flow, blend uniformity, and capsule-filling performance |
| Formulation Options | Single-ingredient peptide capsules or customized peptide, amino acid, protein nutrition, and healthy-aging blends |
| Quality Testing | Protein, peptide content, molecular-weight distribution, moisture, ash, heavy metals, microbiological parameters, and relevant contaminant controls |
| Shelf Life | Typically 24 months when properly packaged and stored under recommended conditions |
| Storage | Store tightly sealed in a cool, dry place protected from direct sunlight, excessive heat, moisture, and contamination |
| Bulk Ingredient Packaging | 1 kg and 5 kg aluminum foil bags; 25 kg fiber drums for applicable bulk requirements; customized protective packaging supported |
| Finished Capsule Packaging | Bottles, jars, and customized private-label packaging formats |
| Order Quantity | Bulk and OEM production supported with commercial quantities adapted to peptide specification, capsule configuration, formula, and packaging requirements |
The most useful technical fingerprint for Bovine Bone Marrow Peptide is molecular-weight distribution rather than a single headline purity percentage. Unlike vitamins or isolated compounds, peptide ingredients contain many peptide chains. Their molecular-size profile reflects the degree of hydrolysis and can influence solubility, processing behavior, sensory characteristics, and formulation positioning.
| Specification | What It Indicates | Buyer Consideration |
|---|---|---|
| Total Protein | Overall protein-derived material measured by an appropriate protein method | Useful for general composition control but does not define peptide size |
| Peptide Content | Proportion represented by peptide fractions under the stated analytical method | Method and calculation basis should be reviewed when comparing products |
| Low-Molecular-Weight Peptides | Percentage of peptides below a defined molecular-weight threshold | Provides more useful information about hydrolysis and peptide-size distribution |
| Molecular-Weight Distribution | Distribution of peptide fractions across defined molecular-size ranges | Preferred for comparing hydrolysis consistency between commercial batches |
A high protein result does not necessarily mean that the ingredient contains a high proportion of low-molecular-weight peptides. Protein assays measure overall nitrogen-derived protein content, while peptide profiling provides information about hydrolysis. Buyers should therefore compare protein, peptide content, molecular-weight distribution, and analytical methods together rather than relying on one percentage.
Enzymatic hydrolysis breaks larger proteins into smaller peptide fractions. The choice of enzymes, hydrolysis time, temperature, separation process, and purification conditions can change the resulting molecular-weight distribution. Controlled processing is therefore important for maintaining consistent peptide characteristics from batch to batch.
More extensive hydrolysis can increase the proportion of smaller peptides, but a lower molecular weight is not automatically superior for every application. Excessive hydrolysis may influence sensory characteristics and processing behavior. The appropriate specification should be selected according to the intended capsule formulation and product positioning.
Bovine Bone Marrow Peptide Capsules can be developed for peptide nutrition, protein supplementation, healthy-aging, active-lifestyle, and specialized animal-derived nutritional formulations. Product positioning should focus on nutritional composition and formulation characteristics rather than implying that bone marrow peptides diagnose, treat, prevent, or cure medical conditions.
Animal-derived peptide ingredients require stronger source documentation than many conventional plant or synthetic nutritional ingredients. Bovine origin, raw-material traceability, manufacturing controls, and target-market regulatory suitability should therefore be reviewed as part of supplier qualification.
Procurement specifications should also address microbiological quality, heavy metals, moisture, and other relevant contaminants. Documentation requirements may differ between markets, particularly for animal-derived ingredients, so regulatory suitability should be evaluated according to the intended country and finished-product category.
Hydrolysis and purification affect more than peptide size. They can also influence solubility, hygroscopicity, odor, flavor, powder density, and flow characteristics. Although taste is less prominent in capsules than in beverages or powders, sensory quality remains relevant because strong residual animal-derived odors can affect consumer acceptance and manufacturing conditions.
For hard capsules, the practical specification should balance peptide concentration with powder flow and bulk density. Higher active density can reduce required fill volume, while appropriate particle characteristics and excipient selection help maintain capsule-weight uniformity during commercial production.
Bovine Bone Marrow Peptide Capsules can be customized according to peptide specification, molecular-weight profile, capsule shell, serving configuration, complementary nutrients, and packaging format. OEM programs can support both single-ingredient peptide products and multi-ingredient nutritional formulations.
Reliable Bovine Bone Marrow Peptide Capsule production requires control from bovine raw-material sourcing through hydrolysis, purification, drying, blending, and finished-product testing. Production under GMP-standard conditions combined with compositional and microbiological testing supports consistent commercial manufacturing and batch documentation.
A commercially useful Bovine Bone Marrow Peptide specification should define more than total protein. Molecular-weight distribution, peptide content, source traceability, sensory characteristics, and microbiological quality provide a more complete picture of ingredient performance and make supplier comparisons more meaningful for capsule formulation teams.
In-house R&D and testing support, GMP-standard production conditions, customized capsule formulation, private-label packaging, third-party testing options, and stable bulk supply can support projects from peptide ingredient qualification through finished Capsule Manufacturing.
Bulk Bovine Bone Marrow Peptide powder is commonly supplied in sealed 1 kg or 5 kg aluminum foil bags and 25 kg fiber drums for applicable commercial orders. Finished capsules can be packed in bottles, jars, and customized private-label formats. Products should remain sealed and protected from heat, direct sunlight, moisture, and environmental contamination.
There is no universal single-compound CAS number for Bovine Bone Marrow Peptide because it is a complex mixture containing multiple peptide fractions rather than one chemically defined molecule. Procurement specifications should instead focus on bovine source, protein and peptide content, molecular-weight distribution, analytical methods, and relevant quality parameters.
No. Total protein analysis describes overall protein-derived content but does not show how extensively the proteins have been hydrolyzed. Two materials with similar protein values may have different peptide-size profiles. For peptide-focused formulations, buyers should review peptide content and molecular-weight distribution alongside total protein.
Molecular-weight distribution provides information about the size of peptide fractions produced during hydrolysis. It can influence solubility, powder characteristics, sensory properties, and formulation positioning. Buyers should specify the required molecular-weight ranges and analytical method instead of assuming that every product described as a bone marrow peptide has an equivalent composition.
A useful COA should report appearance, protein or peptide content, molecular-weight distribution where specified, moisture, ash, heavy metals, and microbiological parameters. For animal-derived ingredients, buyers should also review source and traceability documentation, manufacturing controls, and other technical documents required for the intended market and product category.
Bovine Bone Marrow Peptide Capsules provide an animal-derived peptide format for peptide nutrition, protein-based wellness, healthy-aging, and specialized nutraceutical products. For B2B sourcing, molecular-weight distribution, peptide content, bovine source control, microbiological quality, sensory characteristics, and capsule-processing performance provide a stronger purchasing basis than total protein percentage alone.
Contact us today to request samples, a COA, technical documents, and a wholesale quotation for Bovine Bone Marrow Peptide Capsules.
Packaging & Delivery
The file is encrypted. Please fill in the following information to continue accessing it
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.